
Helus Pharma, a clinical stage pharmaceutical company focussed on developing novel serotonergic agonists (NSAs), has appointed Jill Conwell as Chief …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

